Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Dec;24(12):1931-3.
doi: 10.1681/ASN.2013090923. Epub 2013 Nov 7.

Sodium reduction in CKD: suggestively hazardous or intuitively advantageous?

Cheryl A M Anderson  1 , Joachim H Ix
Affiliations
Editorial

Sodium reduction in CKD: suggestively hazardous or intuitively advantageous?

Cheryl A M Anderson et al. J Am Soc Nephrol. 2013 Dec.
No abstract available

PubMed Disclaimer

Comment on

  • A randomized trial of dietary sodium restriction in CKD.
    McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell KL. McMahon EJ, et al. J Am Soc Nephrol. 2013 Dec;24(12):2096-103. doi: 10.1681/ASN.2013030285. Epub 2013 Nov 7. J Am Soc Nephrol. 2013. PMID: 24204003 Free PMC article. Clinical Trial.

References

    1. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group: KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 2 (suppl): 337–414, 2012
    1. ClinicalTrials.gov Last accessed on September 1, 2013
    1. McMahon E, Bauer J, Hawley CM, Isbel N, Stowasser M, Johnson DW, Campbell KL: A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol 24: 2096–2103, 2013 - PMC - PubMed
    1. de Brito-Ashurst I, Perry L, Sanders TAB, Thomas JE, Dobbie H, Varagunam M, Yaqoob MM: The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: A randomised controlled trial. Heart 99: 1256–1260, 2013 - PMC - PubMed
    1. IOM (Institute of Medicine): Evaluation of biomarkers and surrogate endpoints in chronic disease, Washington, DC, The National Academies Press, 2010 - PubMed

Substances